Connie Matsui, Director at HALOZYME THERAPEUTICS, INC. (HALO), sold 64,000 shares at $40.13 ($2.6M) on 2021-11-05, disclosed to the SEC on 2021-11-05.
Open-market sale of $2.6M HALO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.13 | 19,452 | $781K | 30.2% |
| 2 | $40.13 | 19,452 | $781K | 30.2% |
| 3 | $40.77 | 12,548 | $512K | 19.8% |
| 4 | $40.77 | 12,548 | $512K | 19.8% |
| Total | $40.38 avg | 64,000 | $2.6M | 100% |
| Filing → |
| ARTL | BUY | 2020-05-04 | $100K | — | Filing → |
| BIIB | SELL | 2007-01-18 | $1.3M | — | Filing → |
| BIIB | SELL | 2006-11-06 | $3.5M | — | Filing → |